Indoleamine 2,3 dioxygenase (IDO) level in predicting the future vascular events in the patients who undergoing coronary angiogram
Not Applicable
Completed
- Conditions
- for trials without interventionIndoleamine 2ƻ dioxygenase level,IDO,marker,significant coronary artery disease
- Registration Number
- TCTR20200626001
- Lead Sponsor
- The Research Division Faculty of Medicine Siriraj Hospital, Mahidol University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 305
Inclusion Criteria
1. Age > 18 years.
2. Willing to participate and able to understand, read and sign the informed consent document.
3. The patients in whom CAD was suspected, and they all underwent coronary angiogram.
4. Baseline laboratory test were obtained.
Exclusion Criteria
1. Patients have no blood collected at enrollment
2. Patients with rheumatoid arthritis
3. Patients with allergic asthma
4. Patients with cancer
5. Patients with gingival fibroblasts
6. Patients with neuropathology of Alzheimer’s disease
7. Patients with transplantation
8. Patients with inflammatory bowel disease
9. Patients with Infectious disease
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IDO activity correlated with coronary artery disease severity one year IDO activity between patients with and without CAD
- Secondary Outcome Measures
Name Time Method IDO activity predicted Clinical endpoints at 1-year one year 1-year MACE or 1-year mortality based on biomarkers